Molecular cross-talk among chromosome fragility syndromes

Genes and Development

Volumn 18, Issue 12, 2004, Pages 1359-1370

  Surrallés, Jordi ^a   Jackson, Stephen P ^b   Jasin, Maria ^c   Kastan, Michael B ^d   West, Stephen C ^e   Joenje, Hans ^f  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA2 PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; GENE PRODUCT; PROTEIN; UNCLASSIFIED DRUG; WERNER SYNDROME PROTEIN;

ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA LIKE DISEASE; BLOOM SYNDROME; BREAST CANCER; CANCER; CHROMATIN STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILITY; CHROMOSOME FRAGILITY SYNDROME; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; DNA RNA HYBRIDIZATION; DNA STRAND BREAKAGE; FANCD2 GENE; FANCONI ANEMIA; GENE; GENE FUNCTION; GENE MUTATION; GENETIC COMPLEMENTATION; GENETIC RECOMBINATION; GENETIC STABILITY; HUMAN; MISMATCH REPAIR; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MOLECULAR INTERACTION; NIJMEGEN BREAKAGE SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SECKEL SYNDROME; SYNDROME; WEGENER GRANULOMATOSIS;

ANIMALS; CHROMOSOME FRAGILITY; DNA DAMAGE; DNA REPAIR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SIGNAL TRANSDUCTION; SYNDROME;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 2942659914     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1216304     Document Type: Conference Paper

References (61)

1. Aguilera, A. 2002. The connection between transcription and genomic instability. EMBO J. 21: 195-201.
2. Aten, J.A., Stap, J., Krawczyk, P.M., van Oven, C.H., Hoebe, R.A., Essers, J., and Kanaar, R. 2004. Dynamics of DNA double-strand breaks revealed by clustering of damaged chromosome domains. Science 303: 92-95.
3. Bakkenist, C.J. and Kastan, M.B. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506.
4. Bassing, C.H., Suh, H., Ferguson, D.O., Chua, K.F., Manis, J., Eckersdorff, M., Gleason, M., Bronson, R., Lee, C., and Alt, F.W. 2003. Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114: 359-370.
5. Bignell, G., Micklem, G., Stratton, M.R., Ashworth, A., and Wooster, R. 1997. The BRC repeats are conserved in mammalian BRCA2 proteins. Hum. Mol. Genet. 6:53-58.
6. Blasco, M. 2003. Telomeres and cancer: A tale with many endings. Curr. Opin. Genet. Dev. 13: 70-76.
7. Blom, E., Van de Vrugt, H.J., De Vries, Y., De Winter, J.P., Arwert, F., and Joenje, H. 2004. Multiple TPR motifs characterize the Fanconi anemia FANCG protein. DNA Repair 5: 77-84.
8. Callén, E., Samper, E., Ramirez, M.J., Creus, A., Marcos, R., Ortega, J.J., Olive, T., Badell, I., Blasco, M.A., and Surrallés, J. 2002. Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Hum. Mol. Genet. 11: 439-444.
9. Carson, C.T., Schwartz, R.A., Stracker, T.H., Lilley, C.E., Lee, D.V., and Weitzman, M.D. 2003. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22: 6610-6620.
10. Castillo, V., Cabre, O., Marcos, R., and Surrallés, J. 2003. Molecular cloning of the Drosophila Fanconi anaemia gene FANCD2 cDNA. DNA Repair 2: 751-758.
11. Celeste, A., Petersen, S., Romanienko, P.J., Fernandez-Capetillo, O., Chen, H.T., Sedelnikova, O.A., Reina-San-Martin, B., Coppola, V., Meffre, E., Difilippantonio, M.J., et al. 2003a. Genomic instability in mice lacking histone H2AX. Science 296: 922-927.
12. Celeste, A., Difilippantonio, S., Difilippantonio, M.J., Fernandez-Capetillo, O., Pilch, D.R., Sedelnikova, O.A., Eckhaus, M., Ried, T., Bonner, W.M., and Nussenzweig, A. 2003b. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114: 371-383.
13. Couëdel, C., Mills, K.D., Barchi, M., Shen, L., Olshen, A., Johnson, R.D., Nussenzweig, A., Essers, J., Kanaar, R., Li, G.C., et al. 2004. Collaboration of homologous recombination and nonhomologous end-joining factors to the survival and integrity of mice and cells. Genes & Dev. 18: 1293-1304.
14. Cox, M.M., Goodman, M.F., Kreuzer, K.N., Sherratt, D.J., Sandler, S.J., and Marians, K.J. 2000. The importance of repairing stalled replication forks. Nature 404: 37-41.
15. d'Adda di Fagagna, F., Reaper, P.M., Clay-Farrace, L., Fiegler, H., Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N.P., and Jackson, S.P. 2003. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194-198.
16. D'Andrea, A.D. 2003. The Fanconi road to cancer. Genes & Dev. 17:1933-1936.
17. Davies, A.A., Masson, J.-Y., McIlwraith, M.J., Stasiak, A.Z., Stasiak, A., Venkitaraman, A.R., and West, S.C. 2001. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell 7: 273-282.
18. Essers, J., Hendriks, R.W., Swagemakers, S.M., Troelstra, C., de Wit, J., Bootsma, D., Hoeijmakers, J.H., and Kanaar, R. 1997. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell 89: 195-204.
19. Friedberg, E.C., Wagner, R., and Radman, M. 2002. Specialized DNA polymerases, cellular survival, and the genesis of mutations. Science 296: 1627-1630.
20. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C., Hejna, J., Grompe, M., and D'Andrea, A.D. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7:249-262.
21. Gerlich, D., Beaudouin, J., Kalbfuss, B., Daigle, N., Eils, R., and Ellenberg, J. 2003. Global chromosome positions are transmitted through mitosis in mammalian cells. Cell 112: 751-764.
22. Godthelp, B.C., Artwert, F., Joenje, H., and Zdzienicka, M.A. 2002. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene 21: 5002-5005.
23. Houghtaling, S., Timmers, C., Noll, M., Finegold, M.J., Jones, S.N., Meyn, M.S., and Grompe, M. 2003. Epithelial cancer in Fanconi anemia complementation group D2 (FancD2) knockout mice. Genes & Dev. 17:2021-2035.
24. Howlett, N.G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., De Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. 2002. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297: 606-609.
25. Huertas, P. and Aguilera, A. 2003. Cotranscriptionally formed DNA:RNA hybrids mediate transcription elongation impairment and transcription-associated recombination. Mol. Cell 12:711-721.
26. Johnson, R.D. and Jasin, M. 2000. Sister-chromatid recombination is a prominent DNA repair pathway in mammalian cells. EMBO J. 19:3398-3407.
27. Kim, S.T., Xu, B., and Kastan, M.B. 2002. Involvement of the cohesin protein, Smc1, in ATM-dependent and independent responses to DNA damage. Genes & Dev. 16: 560-570.
28. Kraakman-van der Zwet, M., Overkamp, W.J., van Lange, R.E., Essers, J., van Duijn-Goedhart, A., Wiggers, I., Swaminathan, S., van Buul, P.P., Errami, A., Tan, R.T., et al. 2002. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell. Biol. 22: 669-679.
29. Kraakman-van der Zwet, M., Wiegant, W., and Zdzienicka, M.Z. 2003. Brca2 (XRCC11) deficiency results in enhanced mutagenesis. Mutagenesis 18: 521-525.
30. Kutler, D.I., Singh, B., Satagopan, J., Batish, S.D., Berwick, M., Giampietro, P.F., Hanenberg, H., and Auerbach, A.D. 2003. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101: 1249-1256.
31. Levitus, M., Rooimans, M.A., Steltenpool, J., Cool, N.F.C., Oostra, A.B., Mathew, A.G., Hoatlin, M.E., Waisfisz, Q., Arwert, F., De Winter, J.P., et al. 2004. Genetic heterogeneity in Fanconi anemia: Evidence for two new genetic subtypes. Blood 103:2498-2503.
32. Liu, Y., Masson, J.Y., Shah, R., O'Regan, P., and West, S.C. 2004. RAD51C is required for Holliday junction processing in mammalian cells. Science 303: 243-246.
33. Lomonosov, M., Anand, S., Sangrithi, M., Davies, R., and Venkitaraman, A.R. 2003. Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein. Genes & Dev. 17:3017-3022.
34. Marsit, C.J., Liu, M., Nelson, H., Posner, M., Suzuki, M., and Kelsey, K.T. 2004. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: Implications for treatment and survival. Oncogene 23: 1000-1004.
35. Meetei, A.R., De Winter, J.P., Medhurst, A.L., Wallisch, M., Waisfisz, Q., Van de Vrugt, H.J., Oostra, A.B., Yan, Z., Ling, C., Bishop, C.E., et al. 2003a. A novel ubiquitin ligase is deficient in Fanconi anaemia. Nat. Genet. 35: 165-170.
36. Meetei, A.R., Sechi, S., Wallisch, M., Yang, D., Young, M.K., Joenje, H., Hoatlin, M.E., and Wang, W. 2003b. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23:3417-3426.
37. Meetei, A.R., Yan, Z., and Wang, W. 2004. FANCL Replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle 3:179-181.
38. Moynahan, M.E., Pierce, A.J., and Jasin, M. 2001. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell 7: 263-272.
39. Nakanishi, K., Taniguchi, T., Ranganathan, V., New, H.V., Moreau, L.A., Stotsky, M., Mathew, C.G., Kastan, M.B., Weaver, D.T., and D'Andrea, A.D. 2002. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat. Cell Biol. 4: 913-920.
40. Nussenzweig, A., Chen, C., da Costa Soares, V., Sanchez, M., Sokol, K., Nussenzweig, M.C., and Li, G.C. 1996. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382: 551-555.
41. O'Driscoll, M., Cerosaletti, K.M., Girard, P.M., Dai, Y., Stumm, M., Kysela, B., Hirsch, B., Gennery, A., Palmer, S.E., Seidel, J., et al. 2001. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell 8: 1175-1185.
42. O'Driscoll, M., Ruiz-Perez, V.L., Woods, C.G., Jeggo, P.A., and Goodship, J.A. 2003. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33: 497-501.
43. Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S.D., Diotti, R., Schneider, R.H., Deffenbaugh, A., Scholl, T., et al. 2003. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. J. Nat. Cancer Inst. 95: 1548-1551.
44. Pagano, G. and Youssoufian, H. 2003. Fanconi anaemia proteins: Major roles in cell protection against oxidative damage. Bioessays 25: 589-595.
45. Pellegrini, L., Yu, D.S., Lo, T., Anand, S., Lee, M.Y., Blundell, T.L., and Venkitaraman, A.R. 2002. Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature 420: 287-293.
46. Petrini, J.H. and Theunissen, J.W. 2004. Double strand break metabolism and cancer susceptibility: Lessons from the Mre11 complex. Cell Cycle May [Epub ahead of print].
47. Pichierri, P. and Rosselli, F. 2004. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 23:1178-1187.
48. Richardson, C. and Jasin, M. 2000. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405: 697-700.
49. Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S., and Bonner, W.M. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:5858-5868.
50. Seal, S., Barfoot, R., Jayatilake, H., Smith, P., Renwick, A., Bascombe, L., McGuffog, L., Evans, D.G., Eccles, D., Easton, D.F., et al. 2003. Breast cancer susceptibility collaboration. Evaluation of Fanconi anemia genes in familial breast cancer predisposition. Cancer Res. 63: 8596-8599.
51. Sonoda, E., Okada, T., Zhao, G.Y., Tateishi, S., Araki, K., Yamaizumi, M., Yagi, T., Verkaik, N.S., van Gent, D.C., Takata, M., et al. 2003. Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. EMBO J. 22: 3188-3197.
52. Stracker, T.H., Carson, C.T., and Weitzman, M.D. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418: 348-352.
53. Surrallés, J., Ramirez, M.J., Marcos, R., Natarajan, A.T., and Mullenders, L.H. 2002. Clusters of transcription-coupled repair in the human genome. Proc. Natl. Acad. Sci. 99: 10571-10574.
54. Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S.V., Mathew, C.G., Joenje, H., Mok, S.C., and D'Andrea, A.D. 2003. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat. Med. 9: 568-574.
55. Tibbetts, R.S., Cortez, D., Brumbaugh, K.M., Scully, R., Livingston, D., Elledge, S.J., and Abraham, R.T. 2000. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes & Dev. 14: 2989-3002.
56. Tischkowitch, M., Ameziane, N., Waisfisz, Q., De Winter, J.P., Harris, R., Taniguchi, T., D'Andrea, A.D., Hodgson, S.V., Mathew, C.G., and Joenje, H. 2003. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia. Br. J. Haematol. 123: 469-471.
57. Uziel, T., Lerenthal, Y., Moyal, L., Andegeko, Y., Mittelman, L., and Shiloh, Y. 2003. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22: 5612-5621.
58. West, S.C. 2003. Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol. 4: 435-445.
59. Wong, A.K.C., Pero, R., Ormonde, P.A., Tavtigian, S.V., and Bartel, P.L. 1997. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene BRCA2. J. Biol. Chem. 272:31941-31944.
60. Yamashita, Y.M., Okada, T., Matsusaka, T., Sonoda, E., Zhao, G.Y., Araki, K., Tateishi, S., Yamaizumi, M., and Takeda, S. 2002. RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells. EMBO 21:5558-5566.
61. Yu, D.S., Sonoda, E., Takeda, S., Huang, C.L., Pellegrini, L., Blundell, T.L., and Venkitaraman, A.R. 2003. Dynamic control of RAD51 recombinase by self-association and interaction with BRCA2. Mol. Cell 12: 1029-1041.